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 Neisseria gonorrhoeae is an obligate human pathogen responsible for causing 
the disease gonorrhea.  These organisms are facultatively anaerobic, gram (-) cocci 
that are generally arranged in pairs (diplococci), with flattened sides adjacent to each 
other.  They are catalase (+), oxidase (+), and non-motile.  The bacterium utilizes 
carbohydrates oxidatively.  N. gonorrhoeae normally colonizes the mucosal surfaces 
of humans, predominantly the urethra, cervix, and other parts of the urogenital tract.  
Ocular infections can occur due to infant passage through an infected birth canal. 
 
 Gonorrhea is one of the most common sexually transmitted diseases.  The 
disease usually manifests itself in males as an acute anterior urethritis, accompanied 
by the onset of dysuria and discharge of a purulent exudate.  Rarely, the primary 
infection can spread locally, leading to conditions such as epididymitis, seminal 
vesiculitis, and prostatitis (Hart and Rein 1976).  Female gonococcal infection usually 
results in increased vaginal discharge, increased urinary frequency, and uterine 
bleeding.  In ~15% of women infected with N. gonorrhoeae, the primary infection will 
lead to further complications, such as endometritis and pelvic inflammatory disease 
(PID).  Unfortunately, PID frequently leads to sterility and contributes to ectopic 
pregnancies (Curran, Rendtorff et al. 1975; Hook and Holmes 1985).  
 
 N. gonorrhoeae has a significant impact on human health.  In 2001, over 
350,000 cases of gonorrhea were reported in the United States (CDC 2002).  Health 
economists estimate that costs associated with treatment of these gonococcal 
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infections approach 1.1 billion dollars per year (NIAID 2002).  Also, there is evidence 
suggesting that gonococcal infections facilitate transmission of the human 
immunodeficiency virus (HIV) (Cohen, Hoffman et al. 1997). 
 
 N. gonorrhoeae can infect many anatomical locations, with each niche 
possessing its own unique physiological properties.  In order to successfully establish 
itself in these different environments, the gonococcus must be able to adapt to its 
surroundings.  The bacteria must produce various cell surface components such that 
the appropriate components are expressed in the appropriate environments.  To 
facilitate this, N. gonorrhoeae has developed genetic mechanisms that allow for high 
frequency antigenic variation of various cellular components.  These include: 
intramolecular recombination for pili antigenic variation (Meyer, Mlawer et al. 1982); 
changes in the number of pentameric DNA repeat sequences for opacity associated 
protein (Opa) expression (Stern, Brown et al. 1986); and changes in the length of 
homopolymeric tracts for lipooligosaccharide (LOS) variation (Danaher, Levin et al. 
1995), hpuA expression (Chen, Elkins et al. 1998), pilC expression (Jonsson, Nyberg 
et al. 1991), and pgtA expression (Banerjee, Wang et al. 2002). 
 
 Pili are cell surface structures that mediate the initial attachment of the 
gonococcus to host cell surfaces (Swanson 1973).  pilE encodes the pilin protein, a 
major subunit of pili.  Modified or truncated forms of this gene are found in silent sites 
clustered throughout the gonococcal genome.  Antigenic variation of pili results from 
the nonreciprocal transfer of partial pilin sequence information from a silent site into 
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pilE (Hagblom, Segal et al. 1985; Haas and Meyer 1986).  Pilin variation can lead to 
changes in immunoreactivity, posttranslational modification, or adhesive function of 
the mature pili. 
 
Opa are outer membrane proteins that are important for adhesion and invasion 
of epithelial cells.  The opa genes contain multiple copies of the pentameric DNA 
sequence (CTCTT).  Changes in the number of pentameric repeats occurs during DNA 
replication, producing reading frame changes that result in the phase variable 
expression of these genes (Stern, Brown et al. 1986).  This variation can result in 
organisms expressing zero, one, or multiple differing Opa proteins (Dehio, Gray-
Owen et al. 1998). 
 
Opa variation is biologically important because changes in Opa expression 
alter its binding specificity.  For example, the Opa30 variant has been shown to bind 
heparin sulfate proteoglycan (HSPG) receptors (van Putten and Paul 1995).  Opa50 
binds vitronectin, a surface component involved in phagocytosis of apoptotic cells 
(Dehio, Gomez-Duarte et al. 1998), indicating a possible role for Opa50 in promoting 
bacterial uptake into host cells via phagocytosis-like mechanisms.  Also, some Opa 
variants bind members of the CD66 family of proteins (Virji, Makepeace et al. 1996; 
Virji, Watt et al. 1996).  Furthermore, changes in Opa alter the type of host cell 
response induced (Virji, Watt et al. 1996). 
 
 4
 The variable expression of several genes can occur due to homopolymeric 
frameshifting events that occur during DNA replication.  An example is pilC, which 
encodes a protein that provides gonococcal pili with its adhesive properties.  pilC 
expression is governed by a homopolymeric run of guanines; when translation of pilC 
is shifted out of frame due to changes in the number of guanine residues, functional 
PilC is not produced.  Gonococcal pilus fibers that lack PilC do not support epithelial 
cell adherence (Rudel, van Putten et al. 1992).  Another gonococcal gene, pgtA, 
contains a polyguanine tract within its coding sequence.  pgtA encodes a galactosyl 
transferase involved in adding a galactose residue onto the O-linked N-
acetylglucosamine (GlcNAc) of pilin glycan.  Phase variable expression of pgtA 
appears to play a role in promoting the conversion of uncomplicated gonorrhea to 
disseminated gonococcal infection (Banerjee, Wang et al. 2002). 
 
 Another example of a polyguanine mediated phase variable gene is hpuA, a 
gene that encodes a gonococcal outer membrane protein involved in the binding of 
hemoglobin.  Because mammalian hosts use iron binding proteins and iron 
sequestering compounds to maintain free iron at a level that is too low to support 
growth of invading bacterial pathogens (Weinberg 1978), successful colonization 
requires the ability to adapt to iron replete conditions.  Expression of hpuA allows 
gonococci to use hemoglobin as the sole source of iron for growth, eliminating the 
necessity for scavenging iron from transferrin or lactoferrin compounds.  This phase 
variable receptor is selected for in vivo in women during the first half of the menstrual 
cycle (Anderson, Leone et al. 2001), and it has been hypothesized that phase variation 
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of this receptor enables efficient utilization of menstrual hemoglobin (Chen, Elkins et 
al. 1998). 
 
 LOS molecules are immunogenic glycolipids found on the surface of the outer 
membranes of Neisseria species.  LOS molecules contain three domains:  a lipid A 
region, a core polysaccharide structure, and branched oligosaccharide side chains.  
LOS closely resembles lipopolysaccharide (LPS) from enterics such as E. coli or 
Salmonella species; however, LOS molecules lack an O-antigen.  This outer surface 
component is very important for Neisseria pathogenesis, being involved in processes 
such as immune evasion, attachment, and tissue damage (Ward, Watt et al. 1974; 
Gregg, Johnson et al. 1981).  Each gonococcal strain has the ability to make 
structurally related forms of LOS, which can be distinguished by the monoclonal 
antibodies they can bind (Gibson, Webb et al. 1989). 
 
 Many genes involved in LOS biosynthesis have been cloned and characterized 
(Gotschlich 1994).  Synthesis of the LOS α chain is initiated by lgtF, which encodes a 
glycosyl transferase that adds a glucose residue to the first heptose molecule in the 
LOS structure.  The lgt gene cluster, consisting of genes lgtA, lgtB, lgtC, lgtD, and 
lgtE, is responsible for the addition of various sugars to the LOS α chains.  lgtA, lgtC, 
and lgtD contain polyguanine tracts within their coding sequences.  The number of 
guanine residues in each gene determines if it will encode a functional protein. Since 
sugars are added to a growing oligosaccharide, the loss of function of a protein early 
in the biosynthetic process will produce truncated LOS molecules.  lgtG, which is 
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responsible for initiating β chain synthesis, contains a polycytosine tract.  When this 
gene is out of frame, the bacterium does not add a β chain onto its LOS. 
 
 LOS phenotypic variation occurs at a frequency of ~10-3/cell/generation, 
suggesting that replicational frameshifting should occur at this frequency (Apicella, 
Shero et al. 1987; Schneider, Hammack et al. 1988).  However, no studies have been 
performed to correlate genotypic and phenotypic variations in Neisseria.  Furthermore, 
the influence of the length of a polynucleotide run on frameshifting is unknown.  
 
 The addition of bases due to frameshifting leads to the affected genes being 
expressed out of frame and resultant protein products that are not functional.  For 
example, if the glycosyl transferases produced by the lgt gene cluster are not 
functional, truncated structures of LOS are formed.  Figure 1 is a diagram of the 
composite structure of N. gonorrhoeae LOS.  If lgtA is out of frame, termed “off,” the 
glucose (Glc) and galactose (Gal) molecules proximal to the first heptose molecule 
(Hep1) can be added to the LOS α chain correctly, but an N-acetyl glucosamine 
(GlcNAc) molecule cannot be added due to the lack of LgtA.  This truncated structure 
represents lactosyl LOS.  If lgtC is “on” in the absence of functional LgtA, an 
alternative α chain is formed that contains a glucose molecule and two adjacent 
galactose molecules.  If lgtA is “on” and lgtD is “off,” a lacto-N-neotetraose structure 






   
 
Figure 1 – Composite structure of Neisseria gonorrhoeae LOS.  Genes involved in 
LOS biosynthesis are indicated.  Monoclonal antibody reactivities are underlined.  
Dotted lines represent alternative LOS structures.  *, represents sites where PEA or 
phosphate can be added.(Tong, Reinhold et al. 2001) 
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The various forms of LOS appear to be associated with differing levels of 
gonococcal pathogenicity.  For example, Schneider et al. (1995) demonstrated that a 
gonococcal variant expressing the lacto-N-neotetraose form of LOS was more 
infectious than a gonococcal variant exhibiting a lactosyl LOS (Schneider, Cross et al. 
1995).  Tong et al. (2002) showed that N. subflava 44 expresses a limited amount of 
lacto-N-neotetraose LOS, while N. gonorrhoeae PID2 produces numerous LOS 
structures related to the lacto-N-neotetraose LOS molecules (Tong, Arking et al. 
2002).  Also, induction and persistence of symptomatic urethral gonorrhea require that 
the infectious strain antigenically shift to a variant that produces a high molecular 
weight LOS structure (Schneider, Griffiss et al. 1991).  The aforementioned genes are 
by no means the only phase variable genes in the gonococcus, but this sampling shows 
that phase variability can have a major impact on the pathogenicity of N. gonorrhoeae. 
 
Because the majority of these variation mechanisms require the occurrence of 
DNA mismatches, it suggests that N. gonorrhoeae might be defective in DNA repair. 
DNA repair mechanisms have been well characterized in E. coli, but very little is 
known about these repair mechanisms in the pathogenic Neisseria.  The availability of 
both gonococcal and meningococcal genome sequences has facilitated the 
identification and comparison of potential Neisserial DNA repair genes to the E. coli 
paradigm (Kline, Sechman et al. 2003).  
 
One of the most important DNA repair systems in bacteria is the SOS 
response.  The E. coli SOS system is induced in response to DNA damage, such as 
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thymine dimers resulting from UV irradiation.  In an uninduced cell, LexA acts as a 
repressor of more than 20 genes, including the recA and lexA genes, by binding to 
specific operator sequences upstream of these genes.  Although recA and lexA are 
considered repressed, a small level of each of these proteins is produced during this 
repressed state.  During DNA damage, regions of single-stranded DNA are produced, 
and the binding of RecA to these single-stranded regions appears to convert RecA to 
an “activated” form (RecA*).  RecA* interacts with LexA, resulting in proteolytic 
cleavage of LexA and the increased expression of the various SOS genes, such as the 
umuDC operon.  UmuD’ (a modified form of UmuD resulting from RecA-facilitated 
self-cleavage), UmuC, and RecA are thought to work in concert with DNA 
polymerase III to carry out translesion synthesis, enabling replication over DNA 
lesions that would otherwise be strongly blocking (Friedberg, Walker et al. 1995; 
Smith and Walker 1998).  There is no known SOS system in the Neisseria, as no SOS 
boxes or LexA homologues have been found in the Neisserial genomes (Roe, Clifton 
et al. 1997; Black, Fyfe et al. 1998). 
 
 E. coli possesses a nucleotide excision repair mechanism that appears to 
counter many different types of DNA lesions with differing chemical and structural 
properties (Rupp 1996).  The protein products of uvrA and uvrB form a complex that 
recognizes and binds to many types of bulky DNA adducts.  A third protein, UvrC, 
interacts with UvrB and both of these proteins make DNA incisions that facilitate the 
removal of a small region of DNA that contains the DNA damage being repaired.  
DNA polymerase synthesizes a new strand of DNA to replace the excised fragment.  
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All of the genes encoding components of the nucleotide excision repair pathway 
(uvrA, uvrB, uvrC, uvrD, and mfd) are present in the sequenced genomes of Neisseria 
(Kline, Sechman et al. 2003). 
 
 The base excision repair pathway in E. coli begins when a damaged base is 
removed by a DNA N-glycosylase that severs the bond linking the base to the sugar-
phosphate backbone of DNA.  This now abasic site is removed through nuclease 
activity, and the resulting gap is filled with new DNA by DNA polymerase.  Base 
excision repair pathway homologues (nth, tag, mutMTY, xthA, ogt, and fgp) can be 
found in the Neisseria genomes; however, the Neisseriae lack homologues of the 
endonuclease nfo and the glycosylase nei.  It is thought that molecules with redundant 
functions may allow for the absence of these two genes or lesions recognized by Nfo 
and Nei may be rare (Kline, Sechman et al. 2003). 
 
 Photoreactivation is a process used by E. coli to repair pyrimidine dimers 
without having to excise any portion of DNA.  The photoreactivating enzyme 
photolyase attaches to pyrimidine dimers that form during UV irradiation of DNA.  
Upon exposure to light, methylenetetrahydrofolate absorbs energy from the light and 
transfers it to reduced flavin adenine dinucleotide.  This intermediate transfers an 
electron to the dimer to split it.  Further electron transfers restore the original 
pyrimidines and regenerate the DNA photolyase enzyme (Sancar 1994).  Although N. 
gonorrhoeae has been reported to lack a photoreactivation system (Campbell and 
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Yasbin 1979), a potential homologue to the photolyase enzyme encoded by the phr 
gene is present in the sequenced genomes of both N. gonorrhoeae and N. meningitidis. 
 
VSP (very short patch) repair in E. coli functions to correct thymine-guanine 
mismatches in the context of the sequence -CC(A/T)GG-.  If the second cytosine in 
this sequence is methylated at position 5 by Dcm, it can spontaneously deaminate to 
form a thymine, resulting in a thymine-guanine mismatch.  The vsr gene product, Vsr 
endonuclease, creates a nick just upstream of the mispaired pyrimidine to initiate the 
repair process.  This strand specific nicking is followed by conventional DNA 
polymerase I-dependent excision repair (Hennecke, Kolmar et al. 1991).  Homologues 
of genes involved in VSP repair can be identified in the Neisseria genomes (Kline, 
Sechman et al. 2003). 
 
The most studied DNA repair system in the Neisseriae is the recombinational 
repair system.  Recombinational repair can be mediated in E. coli by either the 
RecBCD or RecF pathway of homologous recombination (Kowalczykowski, Dixon et 
al. 1994).  The RecBCD pathway is the major pathway for recombination in wildtype 
E. coli.  The RecF pathway facilitates recombination events in recBC mutants in the 
presence of sbcBC suppressor mutations (Kowalczykowski, Dixon et al. 1994).  The 
Neisseriae contain many genes from both of these pathways, and many of these genes 
have been shown to play a role in DNA repair (Koomey and Falkow 1987; Mehr and 
Seifert 1998; Stohl and Seifert 2001; Skaar, Lazio et al. 2002).  Although homologues 
of certain RecF pathway components are present in Neisseriae, a RecF homologue has 
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not been identified, leading to the designation of a RecF-like pathway in these 
organisms (Mehr and Seifert 1998).  Based on a lack of sbcBC homologues in N. 
gonorrhoeae and the decreased repair phenotypes of RecF-like pathway mutants, it 
has been suggested that the gonococcus behaves similarly to an E. coli sbcBC mutant 
such that the RecF-like pathway is active in wildtype cells (Mehr and Seifert 1998), 
probably due to the fact that recombinational repair pathways are more important for 
Neisseriae, which lack an SOS response (Kline, Sechman et al. 2003). 
 
Mismatch repair (MMR) is a mechanism that processes mismatches between 2 
undamaged normal bases that cannot form classic Watson-Crick base pairs (Rupp 
1996).  The majority of our understanding of mismatch repair comes from studies 
performed on the methyl-directed MMR pathway of E. coli.  There are three basic 
steps involved in E. coli mismatch repair:  recognition of a DNA mismatch, excision 
of the misincorporated base(s) and DNA surrounding the mismatch, and replacement 
of excised DNA.  To begin, a DNA mismatch is recognized by the MutS protein.  The 
MutL protein, together with the MutS-DNA mismatch complex, stimulate strand 
scission by MutH, which makes nicks opposite a dam-methylated GATC parental 
DNA sequence.  Because newly synthesized strands of DNA will not be fully 
methylated immediately, making nicks in DNA opposite a dam-methylated sequence 
ensures that the integrity of the parental strain will remain intact.  After nicking of the 
DNA, exonuclease reactions are catalyzed by either ExoVII or RecJ from one side of 
the mismatch or Exonuclease I from the other side of the mismatch.  Finally, DNA 
polymerase III and SSB proteins replace the excised DNA with new sequence 
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(Grilley, Griffith et al. 1993; Modrich 1994).  The pathogenic Neisseriae possess 
homologues to genes known to be involved in E. coli methyl-directed mismatch 
repair, including mutS and mutL but lacking mutH (Richardson and Stojiljkovic 2001).  
Although pathogenic Neisseriae lack MutH, which is responsible for the initial nick of 
a newly synthesized, unmethylated strand of DNA, it has been hypothesized that the 
strand recognition system in Neisseriae may be more similar to eukaryotic organisms 
and could be directly linked to replication apparatus (Holmes, Clark et al. 1990; 
Petranovic, Vlahovic et al. 2000). 
 
Although some information about gonococcal repair systems has been 
obtained, DNA repair in N. gonorrhoeae has not been well characterized.  
Understanding gonococcal repair systems would enhance our knowledge about 
prokaryotic DNA repair in general as well as give insight into the understanding of 
gonococcal pathogenesis.  Although many genes in N. gonorrhoeae contain 
homopolymeric nucleotide repeats, which should represent possible hot spots of 
mutation, this organism does not appear to be hypermutable.  In fact, observations 
indicate that this organism is hypomutable (Campbell and Yasbin 1984), with 
mutation frequencies occurring about 10 fold less often than what is seen in E. coli 
(Baquero, Nilsson et al. 2004).  However, neisserial mutY mutants have been shown to 
have a hypermutable phenotype in both meningococci and gonococci when inactivated 
(Davidsen, Bjoras et al. 2005).  This paradox implies that the gonococcus has a novel 
method of maintaining genome stability and repairing DNA mismatch events.  
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The study of homopolymeric frameshifting in N. gonorrhoeae has been 
hampered by the lack of a selection method for measuring mutation frequencies.  
Schneider et al used immunoelectron microscopy and monoclonal antibody binding 
patterns to demonstrate that N. gonorrhoeae strain 4505 was able to vary its LOS 
expression (Schneider, Hammack et al. 1988).  Although this phenotypic screen 
yielded an observed LOS variation frequency, the variation in LOS expression could 
not be directly attributed to changes in the homopolymeric nucleotide repeats found in 
the phase variable LOS biosynthetic genes.  Furthermore, because the scoring of phase 
variation is a subjective measure, it is possible that Schneider et al. could have over- or 
under-estimated the true phase variation frequency. 
 
The goal of the research presented here was to use molecular biology 
techniques to study and assess frameshifting frequencies in N. gonorrhoeae FA1090.  
To accomplish this, a reporter system was created that could allow for positive 
selection of frameshifting events while maintaining the viability of the affected 
organism.  This reporter system involved the manipulation of a gonococcal 
nitroreductase gene and its effects on gonococcal resistance to nitroaromatic 
compounds. 
 
Nitroreductases have been identified in a wide variety of microorganisms.  
They were originally studied because they play a role in the reductive activation of 
various nitroaromatic antimicrobials, such as nitrofurantoin, nitrofurazone, and 
furazolidone.  Although the biological role of nitroreductases in bacteria is unknown, 
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strains lacking nitroreductases are more resistant to nitroaromatic compounds 
(Whiteway, Koziarz et al. 1998).  The antimicrobial actions of nitrofurantoin, 
nitrofurazone, and furazolidone are all dependent on the reduction of the nitro groups 
found in these compounds.  Although the starting and ending products of this 
nitroreduction lack antimicrobial activity, it is believed that the reactive oxygen 
intermediates produced during this reaction can damage DNA and may inhibit 
bacterial protein synthesis (McOsker and Fitzpatrick 1994; Greenwood 2000). 
 
Because the loss of gene function results in resistance to an antimicrobial 
agent, these genes provide an ideal starting point for studying spontaneous mutation.  
Database searches were used to identify potential nitroreductases in N. gonorrhoeae.  
The biochemical properties of these putative nitroreductases were verified, and a 
nitrofurantoin-based reporter system was developed that allowed for the determination 
of spontaneous mutation frequencies due to homopolymeric tracts in N. gonorrhoeae. 
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Materials and Methods 
Bacterial Strains, Plasmids, and Oligonucleotides 
 All bacterial strains, plasmids, and oligonucleotide primers used in this study 
are listed in Table 1, Table 2, and Table 3. 
 
Bacterial Growth and Storage Conditions 
 All media and solutions used in this study are described in Table 4.  All 
Neisseria strains were grown in GCP broth plus growth supplements (White and 
Kellogg 1965) and 0.042% sodium bicarbonate or on GCK agar plates plus growth 
supplements (Difco, Detroit, MI) in a 37°C, 6% CO2 incubator.  E. coli strains were 
grown in LB broth or on LB agar plates.  When needed, antimicrobials were added to 
the growth media as follows:  kanamycin, 50µg/mL; spectinomycin, 50µg/mL; and 
nitrofurantoin, 3µg/mL. When screening for β-galactosidase activity, X-gal was added 
to the medium (35µg/mL). All strains were stored at -80°C in GCP or LB broth 
supplemented with 20% glycerol.  Optical densities of gonococcal and E. coli cultures 
were determined using a Klett-Summerson colorimeter fitted with a green filter.  One 
Klett unit corresponds to a culture density of approximately 5 x 106 CFU/mL. 
 
Chemicals, Reagents, and Enzymes 
 Restriction enzymes and T4 DNA ligase were purchased from New England 
Biolabs (Beverly, MA).  All chemicals used in this study were reagent grade or better 
and were purchased from Sigma (St. Louis, MO) unless otherwise specified.   
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Table 1 – Bacterial 
Strains Used 
  
   
Strain Phenotype Source 
Neisseria gonorrhoeae 
FA1090 
 P. Frederick Sparling 
N. gonorrhoeae FA19  William Shafer 
N. gonorrhoeae FA853  P. Frederick Sparling 
N. gonorrhoeae F62  P. Frederick Sparling 
N. gonorrhoeae MS11  Herman Schneider 
N. gonorrhoeae PID2   
FA1090 nfsB (mod) 
polyG-5 
Spcr; contains 5-residue 
polyG tract 
This study 
FA1090 nfsB (mod) 
polyG-6 
Spcr; contains 6-residue 
polyG tract 
This study 
FA1090 nfsB (mod) 
polyG-7 
Spcr; contains 7-residue 
polyG tract 
This study 
FA1090 nfsB (mod) 
polyG-8 
Spcr; contains 8-residue 
polyG tract 
This study 
FA1090 nfsB (mod) 
polyG-9 
Spcr; contains 9-residue 
polyG tract 
This study 
FA1090 nfsB (mod) 
polyG-10 
Spcr; contains 10-residue 
polyG tract 
This study 
FA1090 nfsB (mod) 
polyG-11 
Spcr; contains 11-residue 
polyG tract 
This study 
FA1090 nfsB (mod) 
polyG-12 
Spcr; contains 12-residue 
polyG tract 
This study 
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Table 2 – Plasmids Used   
   
Plasmid Properties Source 
pK18 Gonococcal suicide vector; Kanr RD Pridmore 
pK18-nfsB FA1090 nfsB cloned into pK18 This study 
pK18-nfsB-polyG10 10-residue polyG tract within nfsB This study 
pNFSB-polyG10 Spcr cassette cloned downstream of 
nfsB in pK18-nfsB-polyG10 
This study 
pNFSB-polyG5 5-residue polyG tract within nfsB; 
Spcr 
This study 
pNFSB-polyG6 6-residue polyG tract within nfsB; 
Spcr 
This study 
pNFSB-polyG7 7-residue polyG tract within nfsB; 
Spcr 
This study 
pNFSB-polyG8 8-residue polyG tract within nfsB; 
Spcr 
This study 
pNFSB-polyG9 9-residue polyG tract within nfsB; 
Spcr 
This study 
pNFSB-polyG11 11-residue polyG tract within nfsB; 
Spcr 
This study 









Primer Sequence (5’ > 3’) 
NP1 AAAGGATCCCATGAACGCCATTGCAGACG 
NP2 GGGGGATCCAGAAGATACCATACGCCTCT 
G string 1 AAAAACCGGTTTAAGCAAAGAGCAGGTTCTATCCG 
































GampR +1 ATGCGGATAGAACCTGCTCTTTGC 
GampR -1 GCGGATAGAACCTGCTCTTTGC 
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Gonococcal Base Medium    36.5g 
Bacto-Agar      5.0g 





Protease Peptone #3     15.0g 
Soluble Starch      1.0g 
KH2PO4      1.0g 
K2HPO4      4.0g 
NaCl       5.0g 
HPLC H2O 
 
100X Kellogg’s (1L) – filtered 
 
Glucose      400.0g 
Glutamine      5.0g 
Ferric Nitrate      0.6g 
Thiamine Pyrophosphate    0.02g 
HPLC H2O 
 
Luria Broth (1L) 
 
Bacto-Tryptone     10.0g 
Yeast Extract      5.0g 
NaCl       5.0g 
HPLC H2O 
 
Luria Agar (1L) 
 
Bacto-Tryptone     10.0g 
Yeast Extract      5.0g 
NaCl       10.0g 
Bacto-Agar      15.0g 
HPLC H2O
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Polymerase chain reaction reagents were purchased from Roche Molecular  
 
Biochemicals (St. Louis, MO) or Invitrogen (Carlsbad, CA).  
 
Polymerase Chain Reactions 
 Polymerase chain reaction amplifications were generally performed using 
Platinum PCR Supermix (Invitrogen) or the Expand Long Template PCR kit (Roche).  
Oligonucleotide primers were purchased from Bioserve Biotechnologies (Laurel, MD) 
or Integrated DNA Technologies (Coralville, IA).  PCR products were purified using 
the Qiaquick PCR Purification kit (Qiagen, Valencia, CA). 
 
Restriction Endonuclease Reactions 
 Restriction endonuclease digestions were performed according to 
manufacturer’s recommendations for each enzyme used.  Reaction mixtures were 
incubated at the appropriate temperature for 2-24 hours.  Enzymes were heat 
inactivated according to the instructions from New England Biolabs.  If heat 
inactivation was not possible, phenol chloroform extractions were used to inactivate 
the enzymes prior to purification procedures. 
 
T4 DNA Ligase Reactions 
 DNA ligation reactions were carried out at 4°C or at room temperature.  DNA 
to be ligated was added to 1µL of T4 DNA ligase and the appropriate amounts of T4 
DNA ligase buffer and water.  Ligations were incubated for 2-24 hours. 
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Transformation of E. coli 
 Competent cells of E. coli DH5αMCR were prepared by the method of Inuoe 
(Inoue, Nojima et al. 1990).  The introduction of DNA into E. coli was done using 
competent cells prepared as described above using the standard heat shock protocol 
(Cohen, Chang et al. 1972).  Cells were allowed to express the transforming DNA for 
30-60 minutes prior to plating on appropriate selective agar. 
 
Transformation of N. gonorrhoeae 
 N. gonorrhoeae transformations were done using a tube transformation 
procedure.  Piliated gonococcal cells were suspended in 1mL GCP broth 
supplemented with growth supplements, 0.0042% sodium bicarbonate, and 10 mM 
MgCl2 to a cell density that gave slight turbidity.  DNA (1-10µL) was added to the 
culture, and the bacterial suspension was incubated with shaking at 37°C for 2-4 
hours.  Bacteria were plated onto GCK agar plates supplemented with the appropriate 
antibiotic and incubated at 37°C, in 6% CO2 for 24-48 hours. 
 
Plasmid DNA Isolations 
 Plasmid isolations were carried out using an alkaline lysis protocol  (Birnboim 
and Doly 1979).  The nature of the obtained product was determined by analysis using 





Isolation of Gonococcal Chromosomal DNA 
 Chromosomal DNA was isolated from N. gonorrhoeae by suspending a small 
amount of gonococcal cellular material in 5µL 0.5M NaOH.  This solution was 
neutralized by the addition of 5µL 1M Tris-HCl, pH 7.5.  This suspension was diluted 
into 90µL of purified water.  DNA prepared in this way is suitable for PCR 
amplification. 
 
Nitrofurantoin Plating Procedure 
 Gonococcal cells were suspended in 4mL of GCP broth until a Klett reading of 
100 was achieved.  10-fold dilutions were carried out to a final dilution of 10-6.  100µL 
aliquots from the 10-1, 10-2, and 10-3 dilution tubes were plated on GCK agar plates 
supplemented with 3µg/mL nitrofurantoin.  Aliquots from the 10-5 and 10-6 dilution 
tubes were plated on GCK agar.  Plates were incubated at 37°C, 6% CO2 for 24-48 
hours.  The number of colonies arising on these plates was determined, and the 
mutation frequency obtained was calculated by dividing the number of colonies on the 
selective medium by the total number of colonies obtained. 
 
Agarose Gel Electrophoresis 
 DNA fragments were separated by agarose gel electrophoresis using 1% 
agarose TBE gels.  The location of the DNA within these gels was visualized by 
staining with ethidium bromide (0.5µg/mL), which was added to agarose prior to 
pouring of the gel.  Gels were run at a constant 100 volts for 15-60 minutes. 
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Polyacrylamide Gel Electrophoresis 
 Polyacrylamide gels were electrophoresed using the method developed in our 
laboratory.  Gels were prepared by pouring 18mL of liquid 15% polyacrylamide 
between two 20cm vertical glass plates.  TBE-saturated butanol was layered on top of 
the acrylamide immediately after pouring it.  The acrylamide was allowed to 
polymerize for 1 hour.  The butanol layer was discarded, and the top of the acrylamide 
gel was washed multiple times with hot 1X TBE buffer.  A comb was inserted 
between the glass plates so as not to disturb the integrity of the acrylamide gel.  Hot 
1% agarose was added on top of the acrylamide, and it was allowed to harden for 30 
minutes.  The comb was then gently removed.  Polyacrylamide gels were run at 
constant voltage (1000 volts) for 2-2.5 hours.  Gels were stained in a solution 




 DNA sequencing was performed by Macrogen, Inc. (Seoul, Korea).  PCR 
products to be sequenced were purified using a Qiaquick PCR Purification kit 
(Qiagen, Valencia, CA) and diluted to a final concentration of ~50ng/µL.  20µL of 
PCR product were sent per sequencing reaction.  Plasmids to be sequenced were 
purified using an alkaline lysis procedure (Birnboim and Doly 1979) and diluted to a 
final concentration of ~100ng/µL.  20µL of purified plasmid were sent per sequencing 
reaction.  Primers to be used for sequencing reactions were diluted to 5pmol/µL, and 
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5µL of primer were sufficient for completing 10 sequencing reactions.  Further 
information can be obtained from Macrogen’s website (www.macrogen.com). 
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Results 
I.  Identification of a Putative Reporter System    
Identification of Potential Nitroreductase Genes 
Two nitroreductases have been identified in E. coli; nfsA and nfsB (Zenno, 
Koike et al. 1996; Zenno, Koike et al. 1996).  The amino acid sequences of these two 
genes were used to search the gonococcal genomic DNA sequence database.  
Although no similarities to nfsA were obtained, an open reading frame (ORF) with 
some homology to nfsB was found.  Figure 2 is an alignment of proteins that showed 
significant homology to the gonococcal NfsB homolog.  All of these proteins have 
nitroreductase activity.  The gonococcal sequence shows 25% identity and 44% 
similarity to the E. coli NfsB protein, suggesting that the gonococcal chromosome 
may encode a nitroreductase.  The amino acid sequence of the gonococcal nfsB was 
used to search the GenBank database, and ORFs that possessed significant homology 
to it were identified.  Significant sequence variation was observed in the immediate 
amino terminal end of the protein.  The E. coli gene appeared to be missing the first 5 
amino acids that were contained within the coding sequence for the other genes, 
suggesting that the amino acid sequence at the start of the gene is highly variable and 
not necessarily essential for gene function. 
 
MIC/Spontaneous Mutation Frequency Studies 
 If N. gonorrhoeae possesses a nitroreductase, it should be sensitive to 
antimicrobial agents that are activated by nitroreductases and it should be possible to 




Figure 2 – Amino acid sequence alignments of various nitroreductase genes from 
select organisms.  The amino acid sequence of E. coli NfsB (accession number 
BAA05004) was used to search the genomic databases using a Blast search.  Proteins 
with significant homology to BAA05004 were aligned.  The amino acid sequences 
used were derived from the following strains:  Neisseria gonorrhoeae FA1090, 
NC002946; Neisseria meningitides MC58, NP273846; Haemophilus influenzae, 
Q57431; Bacillus subtilis, O34475; Helicobacter pylori, AAL37284; and 
Agrobacterium tumefaciens str. C58, NP_534964.  
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organism’s loss of nitroreductase activity.  The minimum inhibitory concentration 
(MIC) of nitrofurantoin for several strains of N. gonorrhoeae was determined by a 
plate dilution method.  Briefly, approximately 108 gonococci were spotted onto media 
containing various amounts of nitrofurantoin. The inoculated plates were incubated 
overnight, and the MIC was defined as the amount of nitrofurantoin needed in the 
plate to completely inhibit the growth of the organisms in 24 hours. This analysis 
indicated that the MIC for nitrofurantoin was approximately 2µg/mL.  The plates were 
incubated for an additional 24 hours, and colonies that arose after this incubation step 
were presumptive nitrofurantoin resistant mutants. The spontaneous mutation 
frequency for various gonococcal strains was measured.  The frequencies ranged from 
6.16x10-7 to 6.17x10-9 (Table 5; done in conjunction with Esteban Carrizosa), 
indicating that the mutation frequency associated with this antimicrobial agent varied 
among the different strains of the gonococcus.  Since it was possible to isolate mutants 
that readily grew on media containing levels of nitrofurantoin above the MIC, we 
hypothesized that the mutation responsible for this phenotype was in the coding 
sequence for the putative gonococcal nitroreductase gene. 
 
Evaluation of Nitroreductase Potential in N. gonorrhoeae 
 In E. coli, resistance to nitroheterocyclic compounds occurs in a stepwise 
manner.  Step one is inactivation of nfsA, which produces resistance to low levels of 
nitro compounds.  Step two, resulting in the combined inactivation of nfsA and nfsB, 
yields considerably higher nitroaromatic resistance (Whiteway, Koziarz et al. 1998).  









Table 5 - Spontaneous mutation frequencies to nitrofurantoin 
resistance for various gonococcal strains. 
Strain Spontaneous Mutation Frequency* 
F62 6.17 x 10-9 
FA19 2.92 x 10-8 
FA1090 3.36 x 10-9 
MS11 6.16 x 10-7 
PID2 9.72 x 10-8 
*Gonococcal cultures were suspended to approximately 109 CFU/mL.  
Serial dilutions of each culture were plated on media containing 2µg/mL 
nitrofurantoin, and the number of viable cells for each experiment was 
determined. 
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isolates resistant to 3µg/mL nitrofurantoin and plating them on GCK agar plates 
containing 4µg/mL nitrofurantoin.  No isolates were obtained that could grow on the 
higher level of nitrofurantoin, suggesting that the nfsB homolog is the only 
nitroreductase in the gonococcus able to reduce nitrofurantoin.  Nitrofurantoin 
resistant derivatives were isolated from all strains tested.  Two nitrofurantoin resistant 
derivatives of FA19 were chosen for further biochemical study, FA19(M2) and 
FA19(M3). 
 
Detection of Nitroreductase Activity in N. gonorrhoeae 
 If gonococci become resistant to nitrofurantoin because of the loss of a 
nitroreductase, it should be possible to demonstrate a lack of nitroreductase activity in 
these mutants.  An indirect spectrophotometric assay was performed to measure 
nitroreductase activity in parent and mutant strains of N. gonorrhoeae.  If a bacterial 
strain possesses a nitroreductase, that protein’s reduction of a nitroaromatic substrate 
should be coupled with a consumption of NADPH.  The conversion of NADPH to 
NADP could be monitored by measuring a decrease in absorbance at a wavelength of 
340nm.   
 
 Mutants resistant to nitrofurantoin were identified.  The amount of 
nitroreductase present in these mutants was compared to that found in the parent 
strain.  The OD340 remained relatively constant in FA19(M2) and FA19(M3), 
indicating a lack of nitroreductase activity in these strains (Figure 3; done by Esteban 






Figure 3 – Biochemical analysis of nitroreductase activity in wildtype and mutant 
lysates.  Wildtype cultures possess nitroreductase activity, mutants in nfsB lack 
nitroreductase activity.  Closed circles, wildtype N. gonorrhoeae FA19; open squares, 
mutant with a frameshift mutation in nfsB; open triangles, mutant with a point 
mutation in nfsB; black dashes, reaction carried out in the absence on nitrofurazone 
(FA19 wildtype lysate and 0.2mM NADPH present). 
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level equal to the control sample lacking NADPH, indicating the presence of 
nitroreductase activity.  The inability to isolate mutants with increased resistance to 
nitrofurantoin and the lack of measurable nitroreductase activity in FA19(M2) and 
FA19(M3) suggest that the gonococcus contains a single nitroreductase. 
 
The DNA sequence of the gonococcal nfsB homolog was determined from two 
nitrofurantoin resistant mutants, FA1090(nitro 1) and FA1090(nitro 2).  Primers NP1 
and NP2 were used to amplify the nfsB region from these organisms, and DNA 
sequencing was carried out on the PCR products.  The data indicate that FA1090(nitro 
1) possessed a single base change that introduced a premature stop codon into the 
coding sequence of nfsB.  FA1090(nitro 2) possessed an insertion of a single adenine 
nucleotide in the beginning of the nfsB coding sequence, resulting in a frameshift 
mutation.  This sequence information suggests that the nitrofurantoin resistant 
phenotype is due to the loss of nitroreductase activity. 
 
Analysis of the nfsB Coding Sequence 
 The nfsB DNA sequences for N. gonorrhoeae strains 853, F62, FA19, MS11, 
and PID2 were determined by sequencing PCR products amplified from gonococcal 
chromosomal DNA.  Sequence analysis indicated that the nfsB gene was highly 
conserved, with nucleotide variation limited to two independent single base 
substitutions identified in strains 853 and PID2.  These single base changes resulted in 
amino acid substitutions in NfsB.  Since these proteins were essentially identical, the 
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variability in spontaneous mutation frequencies observed in these strains could reflect 
the different DNA repair capacities of each strain. 
 
II. Identification of the Genetic Basis of Spontaneous Nitrofurantoin Resistant 
Mutants 
*The following work was done collaboratively by Esteban Carrizosa and Robert 
Holder 
Analysis of Spontaneous Mutation in Nitrofurantoin Resistant Mutants 
 Numerous FA1090 nitrofurantoin resistant mutants were isolated, and the 
DNA sequence of nfsB in these strains was determined.  A majority of these mutants 
possessed the insertion of an adenine residue in a run of 5 adenines, suggesting a bias 
for frameshifting during DNA replication at this position.  To eliminate the 
frameshifting bias, this DNA sequence was modified to alter the polyA tract while 
preserving the amino acid sequence.  To accomplish this, the nfsB gene was cloned 
into pK18, resulting in plasmid pK18-nfsB.  Using PCR, the polyA sequence was 
altered to AAGAA, giving rise to plasmid pEC1.  The Ω fragment from pHP45Ω was 
inserted into this construct to yield pEC3. 
 
 A tube transformation using pEC3 as transforming DNA was done to introduce 
the modified nfsB into the FA1090 chromosome.  Transformation mixtures were 
plated on GCK agar containing 50µg/mL spectinomycin, resulting in strain FA1090 
NfsB-BsmI-Ω.  The Ω fragment coding sequence was removed from this strain via the 
spot transformation procedure (Gunn and Stein 1996), resulting in FA1090-
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NfsB(mod).  PCR using primers NP1 and NP2 was done to amplify the modified nfsB 
regions from spot transformants.  Primers S1 and S2 were used for sequencing of these 
amplicons.  Analysis of the obtained sequences indicates that FA1090-NfsB(mod) 
contained the desired sequence modification.  Nitroreductase assays done with this 
strain demonstrate that it possesses wildtype levels of NfsB activity (data not shown). 
 
 The genetic basis of numerous spontaneous nitrofurantoin resistant mutants of 
strain FA1090-NfsB(mod) was determined.  This strain was plated on GCK agar 
containing 3µg/mL nitrofurantoin, and 107 independent mutants that arose from this 
plating were isolated.  Primers NP1 and NP2 were used to amplify the nfsB region 
from these mutants, and primers S1 and S2 were used to determine the DNA sequence 
of these PCR amplicons.  This approach should allow for the identification of 5 
different types of mutations: missense mutations, nonsense mutations, insertions, 
deletions, and mutations that affect nitrofurantoin uptake. 
 
 The data in Table 6 summarize the types of mutations identified by analysis of 
the PCR amplicon sequences.  About 50% of the mutants harbored point mutations, 
25% possessed insertions, and 25% contained deletions.  The largest insertion mutant 
was 13bp in length and the largest deletion was 4bp in length.  None of the multiple 
base insertions greater than 3bp appeared to be the result of duplications in the native 
coding sequence, and none of the deletions appeared to eliminate repeated sequences 
or sequences that contained obvious secondary structure. 
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Table 6. Genetic basis of nitrofurantoin resistance. 
Point           Frameshift Othera
Nonsense Missense Insertions (single site) Deletions (single site)
   
 observed potentialb     Single base 22 Single base 16 3
CAA->TAA 7 2 Transitions   Multiple bases 4 Multiple base 9   
CAG->TAG 11 8 C->T 7           
TCG->TAG 9 4 G->A 1           
GAG->TAG 5 4            
TGG->TGA 1 5            
Total: 33 23 Total: 20 Total: 26 Total: 25   
   
Transitions/transversions 
generated by missense 
mutants 
Transitions/transversions 
generated by nonsense 
mutants 
  
   Total  
C->T 7 19 26  
G->A 1 0 1  
Total # transitionsc  27   
Transversions   
T->A 3  3  
G->C 2  2  
T->G 5  5  
A->C 2 14 16  
Total # of transversionsd  27  
 
aOther are mutations that occurred outside of the coding sequence for nfsB. 
bPotential is the number of times this nonsense mutation could occur within the nfsB coding sequence. 
cTotal # of transitions is the sum of the number of transitions obtained from nonsense mutations plus the number 
obtained from missense mutations. 
dTotal # of transversions is the sum of the number of transversions obtained from nonsense mutations plus the 
number obtained from missense mutations. 
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III. Utilization of the Nitrofurantoin Reporter System 
*The following work was done by Robert Holder 
Construction of N. gonorrhoeae FA1090 nfsB(mod) polyG-10 
 The overall goal of this project was to construct a reporter system that could be 
used to directly measure phase variation frequencies.  This study focused on the 
gonococcal nfsB gene because of how the presence of this gene affects an organism’s 
sensitivity to an antimicrobial agent.  With antibiotics such as kanamycin and 
spectinomycin, the presence of the genes aph(3’)-Ia and aad9, respectively, allow an 
organism to be resistant to these antibiotics.  Genetically interrupting the coding 
sequences of these genes to study phase variation would result in bacteria unable to 
grow in the presence of kanamycin or spectinomycin, which is an immeasurable 
phenotype.  However, the expression of the nfsB gene confers sensitivity to nitrofuran 
antimicrobials.  The insertion of potentially phase variable sequences into the coding 
sequence of this gene would allow for the measurement of phase variation frequency 
because a phase variation event would result in nitrofuran resistant organisms, a 
phenotype that can be measured. 
 
In order to develop this reporter system, a construct was made that had a polyG 
tract inserted into the coding sequence of nfsB, taking special care to maintain the 
correct reading frame of nfsB.  After constructing this modified gene, it needed to be 
incorporated into the chromosome of a test strain and then the nitrofurantoin 
sensitivity of this strain needed to be verified.  After performing these control 
experiments, this reporter system could be used to measure frameshifting frequencies. 
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  Frameshifting events should result in cells that contain an out-of-frame nfsB 
and nitrofurantoin resistant phenotype.  By plating a known amount of modified 
gonococcal cells on media containing a nonpermissive level of nitrofurantoin, 
frequencies associated with frameshifting could be assessed by determining the 
number of nitrofurantoin resistant colonies that arise. 
 
 The first step in assessing frameshifting frequencies due to homopolymeric 
nucleotide tracts was to create gonococcal strains containing modified nfsB genes.  To 
do this, primers NP1 and NP2 were used to amplify the nfsB region from N. 
gonorrhoeae FA1090.  This amplicon was cloned into the BamHI site of the pUC-
based plasmid pK18, resulting in the plasmid pK18-nfsB.  pK18-nfsB was transformed 
into E. coli DH5αMCR, and plasmids were extracted from kanamycin resistant 
transformants using an alkaline lysis procedure (Birnboim and Doly 1979).  Extracted 
plasmids were digested with DrdI to verify the presence of the correct insert; digestion 
with DrdI produced the expected banding pattern when digestion products were run on 
a 1% agarose TBE gel.  Figure 4 is a schematic of the procedure followed.  Figure 5 is 
a gel image of DrdI digestions that demonstrate that the desired modifications were 
introduced into the plasmid.  
   
 The next step in plasmid construction was to insert the desired polyG tract into 
the coding sequence of nfsB.  Amino acid sequence alignments suggested that the first 
few amino acids of NfsB could be modified without hindering protein function 






     
 
                            
 
Figure 5 – Digestion verification of pK18-nfsB.  Plasmids isolated from kanamycin 
resistant transformants were digested with DrdI to verify the presence of the nfsB 
gene.  The expected digested fragment sizes are 2729bp, 1465bp, and 894bp.  Lane 1, 
Lambda DNA-BstEII digest ladder; Lane 2, pK18-nfsB undigested; Lane 3, pK18-
nfsB digested with DrdI. 
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Gstring 2 were used to amplify the entire sequence of this construct.  These two 
primers were designed to anneal immediately after the start codon of the nfsB 
sequence and amplify in opposite directions, thus amplifying the entirety of pK18-
nfsB.  These primers were also designed to incorporate a 9-residue guanine tract and a 
unique AgeI site immediately downstream of the nfsB start codon.  Figure 6 is a 
schematic showing the construction scheme.  Figure 7 shows the nfsB modifications 
introduced.  The introduction of a 9-residue guanine tract actually results in a tract 
length of 10 residues due to the guanine of the start codon.  Digestion of this PCR 
product with AgeI and ligation of the digested product upon itself yielded pK18-nfsB-
polyG10.  This construct was used to transform E. coli DH5αMCR, and plasmids were 
extracted from kanamycin resistant transformants.  The length of 10 guanine residues 
was chosen because phase variable genes in N. gonorrhoeae contain as few as 10 
guanine residues.    
 
Although the pK18 portion of pK18-nfsB-polyG10 does contain a kanamycin 
resistance marker, this portion of the construct does not get incorporated into the 
gonococcal genome during transformation; pK18 does not contain an origin of 
replication that will allow it to replicate in a gonococcal background.  For expression 
of any gene contained on pK18 to occur in the gonococcus, a double crossover event 
must transpire and the gene to be expressed must be transferred into the gonococcal 
chromosome.  To provide for a way of selecting for the desired transformation event, 
the Ω fragment from pHP45Ω (Prentki and Krisch 1984) was amplified using the 





















      M  T  V  L  S  K  E  Q 
 
TGCACGATGGGGGGGGGGACCGGTTTAAGCAAAGAGCAG 




Figure 7 – nfsB sequence modification.  Inserted guanine residues are underlined.  
The novel AgeI site introduced is in italics. 
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dwnstrmF and dwnstrmR were used to amplify the entire sequence of pK18-nfsB-
polyG10, introducing a unique BsrGI site 86bp downstream from the stop codon of 
the nfsB sequence.  The amplified Ω fragment was cloned into this new BsrGI site, 
resulting in pNFSB-polyG10.  This construct was used to transform E. coli 
DH5αMCR, and plasmids were extracted from spectinomycin resistant transformants.  
Figure 8 is a schematic showing how this plasmid was constructed.  Figure 9 is a gel 
image verifying that the Omega fragment had been inserted into this plasmid. 
 
 The modified nfsB coding sequence had to be inserted into a gonococcal 
background.  To attain this, a gonococcal tube transformation was done.  Piliated 
FA1090 cells were suspended into 1 ml of GCP broth supplemented with Kellogg’s 
growth supplement, MgCl2, and sodium bicarbonate until the tube became slightly 
turbid.  2-3µL of pNFSB-polyG10 were added to the tube, and the tube was incubated 
in a rolling bin at 37°C for 4 hours.  After this incubation, 100µL and 250µL aliquots 
were plated onto GCK agar containing 50µg/ml spectinomycin.  Transformants were 
detected after 36-48 hours of incubation at 37°C, 6% CO2.  Figure 10 is a schematic 
that indicates how the transformation occurs. 
 
Verification of Polyguanine Tract Insertion 
The success of the gonococcal transformation relied on the occurrence of a 
double recombination event between the FA1090 chromosome and the pNFSB-
polyG10 transforming DNA.  Because the recombination event could occur in many 







                   
 
Figure 9 – Digestion verification of pNFSB-polyG10.  Plasmids isolated from 
spectinomycin resistant transformants were digested with BsrGI to verify the presence 
of the Omega fragment.  The expected digested fragment sizes are 5103bp and 
2066bp.  Lane 1, Lambda DNA-BstEII digest ladder; Lane 2, pNFSB-polyG10 







had to be verified in all transformants.  Primers NP1 and NP2 were used to amplify the 
nfsB gene from several spectinomycin resistant gonococcal transformants, and these 
PCR products were digested with AgeI.  An AgeI restriction site should only be 
present if the polyguanine tract had been successfully inserted.  Figure 11 shows an 
AgeI digestion of these nfsB fragments.  The data show that the nfsB PCR fragments 
obtained from our transformants were digested with AgeI, indicating the presence of 
the desired polyguanine addition. 
 
Assessing the Frameshifting Frequency Due to a 10-residue Guanine Tract 
 A small number of spectinomycin resistant transformants were streaked for 
confluency onto GCK agar plates.  After streaking, GCK plates were incubated less 
than 24 hours at 37°C, 6% CO2.  The incubation period was held to under 24 hours to 
ensure that the majority of gonococcal cells on these plates were viable at the time of 
their use.  Each transformant was suspended into 3-4 ml of GCP broth and optical 
densities of each culture were determined using a Klett-Summerson colorimeter.  Cells 
were suspended in GCP until a Klett reading of 100 was achieved.  This value was 
equated previously with ~5x108 CFU/mL. 
 
 After acquiring the desired starting cell concentration, aliquots were plated 
onto GCK agar and GCK agar containing 1, 2, and 4 µg/mL nitrofurantoin.  Plates 
were allowed to dry and were then incubated for 48 hours at 37°C, 6% CO2.  Wildtype 
FA1090 was also plated as a control using this same procedure.  After the incubation 






                                 
 
Figure 11 – Digestion verification of gonococcal spectinomycin resistant 
transformant nfsB fragments.  The nfsB gene was amplified from gonococcal 
spectinomycin resistant transformants and digested with AgeI.  The expected 
undigested PCR fragment size is 4514bp.  The expected digested fragment sizes are 
3524bp and 990bp.  Lane 1, Lambda DNA-BstEII digest ladder; Lane 2, mutant nfsB 
undigested; Lane 3, mutant nfsB digested with AgeI. 
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By comparing the number of colonies obtained after growth on GCK agar plates with 
the number of colonies obtained after growth on GCK/nitrofurantoin plates, it was 
possible to determine a mutation frequency associated with a polyG tract of 10 
residues.  Using this plating procedure, a mutation frequency of 9.2x10-4 was 
observed. 
 
Construction of N. gonorrhoeae FA1090 nfsB(mod) polyG-5...12 
 After demonstrating that a nitrofurantoin plating procedure could be used 
successfully to determine mutation frequencies, various parameters associated with 
frameshifting were investigated.  The FA1090 nfsB gene was modified to contain 
polyG tracts of 5-12 residues, in order to measure the effect of tract length on mutation 
frequency.  Since we had preliminary data that indicated that a 5-residue polyA tract 
within N. gonorrhoeae nfsB has a slightly elevated mutation frequency (Carrizosa, 
unpublished data), a tract length of 5 residues was chosen as the shortest polyG tract to 
be investigated.  To determine if polyG tract lengths longer than 10 residues contribute 
to higher frameshifting frequencies, constructs containing 11 and 12-residue polyG 
tracts were also constructed and tested. 
 
 pNFSB-polyG10 was used as a template.  Primers polyG-5, polyG-6, etc., 
were used in conjunction with the primer Gstring 1 to amplify the entirety of the 
pNFSB-polyG10 sequence.  However, the polyG primers were designed so that the 
10-residue polyG template sequence would be replaced with a polyG tract of the 
desired length.  The same PCR/transformation procedure was employed for the 
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construction of each construct, as described above in Figure 6.  Table 7 is a summary 
of all of the plasmid constructs that were made and shows the nfsB sequence 
modifications.  Primers were designed so that they maintained the intact reading frame 
of nfsB after modifications were in place.  PCR amplicons were digested with AgeI 
and religated upon themselves to create intact plasmid DNAs.  These ligation mixtures 
were used to transform E. coli DH5αMCR, and plasmids were extracted from 
spectinomycin resistant colonies using an alkaline lysis procedure (Birnboim and Doly 
1979).  The plasmids produced in this step are referred to as pNFSB-polyG5, pNFSB-
polyG6, etc., in this work.  DNA sequencing was performed on each construct to 
verify that the desired modification had been incorporated.  These plasmids were 
transformed into N. gonorrhoeae FA1090 using the tube transformation procedure 
described previously, resulting in strains N. gonorrhoeae FA1090 nfsB(mod) polyG-5 
through N. gonorrhoeae FA1090 nfsB(mod) polyG-12. 
 
Assessing Frameshifting Frequencies of Remaining FA1090 nfsB(mod) Strains 
 Of the remaining FA1090 nfsB(mod) strains to be tested, FA1090 nfsB(mod) 
polyG-12 and FA1090 nfsB(mod) polyG-8 were randomly selected to be tested first.  
The mutation frequencies observed with these strains were ~1.2x10-3 and ~6.5x10-5, 
respectively.  These values represent the average of ≥3 independent experiments 
plated in triplicate.  The mutation frequencies observed with polyG tracts of 8, 10, and 
12 residues suggested that there was a direct relationship between polyG tract length 
and mutation frequency.  This information prompted the testing of FA1090 nfsB(mod) 





to determine the minimum polyG tract length required for frameshifting.  Using the 
modified nitrofurantoin plating procedure described above, it was observed that polyG 
tracts of 5 residues and 6 residues don’t appear to give significantly elevated 
frameshifting frequencies.  Four independent spectinomycin resistant isolated 
transformants were used for each of these experiments, with no nitrofurantoin resistant 
colonies arising from either of these samples.  The observed mutation frequency of a 
7-residue polyG tract was calculated to be ~6.3x10-3. 
 
Identification of the Genetic Basis of Generated Nitrofurantoin Resistant 
Mutants 
  Because the minimum polyG tract length required for frameshifting appeared 
to be 7 residues, the remainder of the project was focused on FA1090 nfsB(mod) 
polyG-6 and FA1090 nfsB(mod) polyG-7.  The general approach for this portion of 
the project was to amplify the nfsB region from the nitrofurantoin resistant mutants as 
well as their parent cells and compare amplicon fragment sizes on a polyacrylamide 
gel.  The expectation was that fragments obtained from nitrofurantoin resistant 
mutants would appear 1 or 2 base pairs larger than fragments obtained from their 
parent cells after electrophoresis due to the insertion of extra guanine residues during 
cell replication. 
 
 Size markers were produced so comparisons could be made between parent 
and mutant PCR fragments.  To achieve this, using pNFSB-polyG7 as a template, 
primers GampR-1 and GampR+1 were both used in conjunction with the primer 
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GampF to amplify fragment sizes that were 1bp smaller (GampR-1, resulted in 76bp 
fragment) or 1bp larger (GampR+1, resulted in 78bp fragment) than the expected 
fragment size obtained from parent cells.  This design was used in hopes that 
fragments obtained from parent cells, when viewed on a polyacrylamide gel after 
electrophoresis, would show mobility in between these two markers.  Fragments from 
mutant cells were expected to show mobility equal to one of these two markers, 
depending on if the outcome of the frameshift was insertion or deletion of a base.  It 
should be noted that primers GampF and GampR were used to amplify a 77bp marker 
as well.  Figure 12 is a diagram of a mock gel image that shows the expected fragment 
mobilities. 
 
 Of the FA1090 nfsB(mod) polyG-7 parent cell PCR fragments tested, all 
showed mobility corresponding to PCR fragments obtained from wildtype unmodified 
nfsB genes, meaning that they ran lower on the polyacrylamide gel than expected.  
Because wildtype nfsB genes lack the polyG tract, PCR fragments from wildtype cells 
will be smaller and run faster during electrophoresis.  This phenomenon was also 
observed with the FA1090 nfsB(mod) polyG-6 parent cells that were tested.  As for the 
FA1090 nfsB(mod) polyG-7 mutant cells tested, fragments appeared to be a mixture of 
77bp and 78bp fragment sizes, corresponding to the expected parent fragment size as 
well as the expected +1 frameshift fragment size.  Figures 13 and 14 are gel images of 








Figure 12 – Mock gel of expected mutant nfsB fragment mobilities.  The diagram 
depicts the expected results of wildtype and mutant 5’ nfsB PCR analysis.  -1, size 
marker representing 76bp; +1, size marker representing 78bp; A, theoretical 5’ 
wildtype FA1090 nfsB PCR fragment (lacking polyguanine addition; expected size of 
71bp); B, theoretical 5’ FA1090 nfsB(mod) polyG-7 parent nfsB PCR fragment 
(expected size of 77bp); C, theoretical 5’ FA1090 nfsB(mod) polyG-7 mutant nfsB 








       
 
Figure 13 – FA1090 nfsB(mod) polyG-6 5’ nfsB fragment analysis.  Primers 
GampF and GampR were used to amplify the 5’ portion of nfsB from FA1090 
nfsB(mod) polyG-6 parent cells.  Lane 1, size marker representing 77bp; Lanes 2, 3, 
and 4, FA1090 nfsB(mod) polyG-6 parent nfsB fragments.  The expected PCR 










Figure 14 – FA1090 nfsB(mod) polyG-7 5’ nfsB fragment analysis.  Primers 
GampF and GampR were used to amplify the 5’ portion of nfsB from FA1090 
nfsB(mod) polyG-7 parent and mutation (nitrofurantoin resistant) cells.  Lanes 1, 4, 
and 7, size marker representing 76bp; Lanes 3, 6, and 9, size marker representing 
78bp; Lane 2, FA1090 nfsB(mod) polyG-7 parent nfsB fragment; Lanes 5 and 8, 
FA1090 nfsB(mod) polyG-7 mutant nfsB fragments. 
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Analysis of FA1090 nfsB(mod) polyG Parent and Mutant Cells 
 Because the parent cells didn’t appear to be correct genotypically, it was 
necessary to investigate the reasons behind this.  Using apparent wildtype cells for the 
nitrofurantoin plating procedure should not have yielded mutation frequencies similar 
to those observed with phase variation.  The nitrofurantoin plating procedure was 
modified so that parent cells used had been verified as correct through digestion 
procedures.  Gonococcal tube transformations were done using pNFSB-polyG6 and 
pNFSB-polyG7.  20 isolated spectinomycin resistant colonies from each 
transformation (total of 40) were picked and restreaked for isolation onto GCK agar 
containing 50µg/mL spectinomycin and incubated for 24 hours at 37°C, 6% CO2.  
After incubation, 10 isolated colonies from each of the 40 isolation streaks (total of 
400 colonies) were picked and patch plated onto GCK agar containing 50µg/mL 
spectinomycin and again incubated overnight. 
 
 Patched cells were placed in groups of 10, and crude chromosomal DNA 
extractions were done with each group.  To achieve this, a toothpick was used to pick 
up cells from the desired patch position and place them onto a glass slide.  After all ten 
patches had been placed onto the same slide, the cellular material on the slide was 
mixed together.  Another toothpick was used to pick up a small portion of this mixed 
cellular material and suspend it into 5µL of 0.5M NaOH.  5µL of 1M Tris-HCl pH 7.5 
were then added to neutralize the NaOH.  Finally, 90µL of water were added to bring 
the final volume to 100µL.  This process was repeated until 40 “pooled” DNA 
extractions had been completed. 
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 Using these pools as templates, primers NP1 and NP2 were used to amplify the 
nfsB region from these cell mixtures.  The resulting amplicons were digested with 
AgeI to verify the presence of the modified nfsB sequence, and digestion products 
were run on a 1% agarose gel.  Just fewer than 50% of the pools tested contained the 
desired modification, evident by the digestion of the PCR fragment with AgeI.  3 of 
the correct pools for FA1090 nfsB(mod) polyG-6 and 3 of the correct pools for 
FA1090 nfsB(mod) polyG-7 were used for further study.  5 individual patches from 
within each of the correct pools were chosen, and crude chromosomal DNA 
extractions were done with these samples.  Again, using these DNA extractions as 
template, primers NP1 and NP2 were used to amplify the nfsB region from these now 
individual cells.  These amplicons were digested with AgeI, and digestion products 
were run on a 1% agarose gel.  All individual samples tested digested with AgeI, 
suggesting that they all contained the desired modified nfsB sequence.  Figure 15 is a 
gel image of the individual AgeI digestions. 
 
 The previously described steps ensured that samples being tested using the 
nitrofurantoin plating procedure contained the desired mutation to be tested.  3 
individual samples containing a 6-residue polyG tract and 3 individual samples 
containing a 7-residue polyG tract were chosen for nitrofurantoin plating.  For this 
procedure, aliquots from the 10-1, 10-2, and 10-3 dilution tubes were plated onto GCK 
agar containing 3µg/mL nitrofurantoin.  The amount of nitrofurantoin was increased 
from 2µg/mL because the higher concentration of nitrofurantoin yields a higher 
percentage of truly nitrofurantoin resistant colonies (Carrizosa, personal 
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 communication).  Aliquots from the 10-5 and 10-6 dilution tubes were plated onto 
GCK agar alone.  The mutation frequencies observed with FA1090 nfsB(mod) polyG-
6 and FA1090 nfsB(mod) polyG-7 were ~9.09x10-7 and ~2.65x10-3, respectively. 
 
 After calculating mutation frequencies, it was necessary to analyze the cause 
for these mutations.  6 nitrofurantoin resistant colonies from the FA1090 nfsB(mod) 
polyG-6 plating experiment and 18 nitrofurantoin resistant colonies from the FA1090 
nfsB(mod) polyG-7 plating experiment were chosen for further study.  Primers GampF 
and GampR were used to amplify the nfsB region from these nitrofurantoin resistant 
cells as well as their parent cells.  These amplicons were analyzed on a 1% 
agarose/15% polyacrylamide combination gel.  Figure 16 is a gel image of some of 
these samples.  Fragments from parental cells show the same mobility as a 77bp 
fragment, the expected parental cell fragment size.  The majority of fragments 
obtained from nitrofurantoin mutants also appear to be 77bp in length.  One fragment, 
obtained from an FA1090 nfsB(mod) polyG-6 nitrofurantoin mutant, appears to be 
78bp in length. 
 
 To better interpret the outcomes of the mutation events that occurred, the nfsB 
regions from each of the samples tested were sequenced.  Using crude chromosomal 
DNA extractions, primers NP1 and NP2 were used to amplify the nfsB regions from 
the desired samples.  PCR products were purified using a Qiaquick PCR Purification 












Figure 16 – FA1090 nfsB(mod) polyG-6 and polyG-7 5’ nfsB fragment analysis.  
Primers GampF and GampR were used to amplify the 5’ portion of nfsB from FA1090 
nfsB(mod) polyG-6 and polyG-7 parent and mutant cells.  Lanes 1, 8, and 15, size 
marker representing 76bp; Lanes 7, 14, and 20, size marker representing 78bp; Lane 2, 
FA1090 nfsB(mod) polyG-7 parent nfsB fragment; Lanes 3, 4, 5, 6, 9, 10, 11, 12, and 
13, FA1090 nfsB(mod) polyG-7 mutant nfsB fragments; Lane 16, FA1090 nfsB(mod) 
polyG-6 parent nfsB fragment; Lanes 17, 18, and 19, FA1090 nfsB(mod) polyG-6 





Several of the samples sequenced contained mutations in the coding sequence of nfsB 
that could lead to nitrofurantoin resistance.  Four FA1090 nfsB(mod) polyG-6 mutants 
contained single transition mutations:  three mutants contained a C→T transition at 
nucleotide position 59, resulting in a serine→leucine amino acid substitution, and one 
mutant contained a G→A transition at nucleotide position 154, resulting in a glutamic 
acid→lysine amino acid substitution. The serine residue affected is conserved in E. 
coli K12 nfsB, and the glutamic acid residue affected aligns with a conserved putative 
FMN binding region of nfsB (Whiteway, Koziarz et al. 1998).  One FA1090 
nfsB(mod) polyG-6 mutant (Figure 16, lane 17) contained a +1 frameshift mutation in 
the inserted 6-residue polyguanine tract.  This frameshift results in a premature STOP 
codon at amino acid position 16.  All the FA1090 nfsB(mod) polyG-7 mutants 
sequenced contained an intact, in frame nfsB coding sequence. 
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Discussion 
Neisseria gonorrhoeae has the ability to colonize many distinct anatomical 
regions, including the urogenital tract, the oropharynx, and the conjunctiva.  The 
organism relies on the phase variation of certain genes to allow for the expression of 
appropriate surface components in a given physiological niche.  Phase variation can 
also enhance gonococcal survivability, facilitating the processes of immune evasion 
through molecular mimicry and disease dissemination.  However, the study of phase 
variation in N. gonorrhoeae has been impeded by the lack of a positive selection 
system for measuring mutation frequencies.  The goal of this research was to design a 
positive selection based reporter system to study and assess mutation frequencies in N. 
gonorrhoeae.  The analysis of genes whose loss of function would provide for positive 
selection would allow for an unbiased comparative analysis of spontaneous mutations.  
The study of spontaneous mutation in these genes would yield information for future 
studies on factors that might effect antigenic variation.  Furthermore, the system 
provides a model for which questions concerning changes in gene expression as a 
result of frameshifting or other replicational errors can be studied. 
 
A single nitroreductase, nfsB, was identified in N. gonorrhoeae.  The protein 
product of this gene shows 26% amino acid identity and 46% amino acid similarity to 
the E. coli NfsB protein.  Deletion of this coding sequence and biochemical analysis of 
spontaneous nitrofurantoin resistant mutants confirmed that this gene encoded a 
nitroreductase.  Amino acid sequence alignment analysis of various bacterial 
nitroreductases indicated that all of the domains that have been predicted to be 
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important for enzymatic activity are present in gonococcal NfsB.  The nature of 
spontaneous mutation to nitrofurantoin resistance was determined by analyzing where 
mutations occurred in nfsB.  The results of the spontaneous mutation frequency plating 
experiments and the subsequent genetic analysis showed that nitrofurantoin resistance 
could be a target for analyzing gonococcal mutation because the gene exhibited a low 
inherent spontaneous mutation frequency.  This system was modified to measure the 
effect of the length of polynucleotide runs on phase variation by inserting polyguanine 
tracts within the gonococcal nfsB coding sequence. 
 
The data indicate that mutations yielding nitrofurantoin resistance occurred at a 
higher rate in strains containing modified nfsB genes.  The frequency of mutation also 
increased as the length of the polyguanine tract increased.  A homopolymeric run of 5 
guanines did not produce elevated mutation frequencies, while a tract length of 6 
guanines resulted in higher mutation frequencies and frameshifting mutations.  The 
measured mutation frequency of a 12-residue guanine tract was very similar to the 
mutation frequencies observed by Schneider et al in LOS biosynthetic genes 
containing 11-17 guanine residues (Schneider, Hammack et al. 1988).  This similarity 
suggests that the maximal mutation frequency associated with homopolymeric runs is 
about 10-3.  Given that polyguanine tracts as short as 6 nucleotides have elevated 




The use of PCR and polyacrylamide gel electrophoresis proved to be a reliable 
method for quickly identifying nitrofurantoin resistant mutants that contained nfsB 
frameshift mutations.  When nfsB fragments amplified from nitrofurantoin resistant 
mutants were electrophoresed, the presence of insertions or deletions in the nfsB 
coding sequence was easily detected. 
 
During the analysis of nitroreductase mutation frequencies, it was observed 
that strains containing a 7-residue guanine tract within nfsB exhibited a mutation 
frequency similar to that observed with a 12-residue guanine tract.  This frequency 
failed to follow the observed trend that mutation frequency increased as polyguanine 
tract length increased.  Also, sequence analysis of nitrofurantoin resistant 7-residue 
guanine mutants yielded no mutations within the coding sequence of nfsB.  This result 
suggests that second site mutations are responsible for the nitrofurantoin resistant 
phenotype.  This reasoning is supported by the fact that mutations outside of the nfsB 
coding sequence were identified during spontaneous mutation frequency analysis of N. 
gonorrhoeae FA1090 (Table 5).  It can be hypothesized that the proposed second site 
mutations occur at a higher frequency than frameshift mutations within the 7-residue 
guanine tract.  The presence of a second site mutation that results in nitrofurantoin 
resistance would negate the necessity for the nfsB coding sequence to be mutated to 
yield a resistant phenotype. 
 
Frameshifting did not account for all of the mutations identified during 
analysis of mutants containing 6-residue guanine tracts within nfsB.  Similar to the 7-
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residue guanine nfsB example, some of the 6-residue guanine mutants contained intact 
nfsB coding sequences, suggesting that mutation occurred at a secondary site.  
Furthermore, two unique transition mutations were identified, both of which resulted 
in amino acid changes in NfsB, and a nonsense frameshift mutation was identified. 
 
The identification of a nitrofurantoin resistant mutant containing a frameshift 
mutation validates the use of the described nitrofurantoin reporter system as a method 
for studying frameshifting mutations in N. gonorrhoeae.  The sample containing the 
frameshift mutation exhibited a more slowly migrating band upon polyacrylamide 
electrophoresis when compared to parent samples, and this banding pattern was 
supported by sequencing data obtained for this sample.  Also, the samples containing 
point or second site mutations yielded banding patterns that were supported by 
sequencing data.  Importantly, whether a frameshifting mutation was present or not, 
polyacrylamide electrophoresis and sequencing gave equivalent results, indicating the 
accuracy attainable with this novel nitrofurantoin reporter system. 
 
This system can be adapted to study mutation frequencies associated with a 
variety of systems generating genetic variation.  While this work focused on mutation 
frequencies associated with polyguanine tracts, simple modifications to the reporter 
system could allow for the study of the effects of polyadenine, polycytosine, and 
polythymine tracts on mutation frequencies.  Also, this novel system can be used to 
study antigenic variation not governed by homopolymeric runs.  For example, 
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insertions of the pentameric repeat sequence CTCTT could facilitate the investigation 
of mutation frequencies associated with Opa protein variation. 
 
More experimentation needs to be done to optimize the conditions for use with 
this reporter system.  By analyzing a larger number of 6-residue and 7-residue 
polyguanine tract nitrofurantoin mutants, a more accurate assessment of mutation 
frequencies could be achieved.  Also, sequence analysis could be expanded to include 
the nfsB promoter region in these mutants, which could give insight into the nature of 
some of the second site mutations that have yet to be identified in the current study.  
The importance of further experimentation with this process has already been 
recognized.  In work done since the completion of this project, it has been determined 
that a 5-residue homopolymeric tract results in an elevated mutation frequency to 
nitrofurantoin resistance.  Also, the system has been modified to include the use of 
denaturing gradient gel electrophoresis (DGGE) as a better method of quickly 
identifying frameshift mutations. 
 
In summary, the use of nfsB as a novel reporter system has proven successful 
in measuring gonococcal mutation frequencies.  Elevated mutation frequencies have 
been observed in nfsB mutants containing a homopolymeric run as short as 5 
nucleotides, suggesting that any gene containing a short polynucleotide run has the 
potential to phase vary.  The nature of gonococcal mutations identified with this 
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